Massachusetts Cannabis Corruption Cases: Investigations and Prosecutions

Executive Summary

Massachusetts has emerged as a focal point for cannabis industry corruption investigations, with multiple high-profile cases exposing bribery, extortion, and influence-peddling schemes that have undermined the state's regulated marijuana market. The most prominent case involves Suffolk County Sheriff Steven Tompkins, who faces federal extortion charges for allegedly demanding payments from cannabis license applicants in exchange for favorable treatment. These corruption scandals have revealed systemic vulnerabilities in Massachusetts' cannabis licensing framework, raising questions about equity program integrity, regulatory oversight, and the influence of political connections in an industry designed to promote social justice. The cases have resulted in federal indictments, license revocations, and calls for comprehensive reform of the Cannabis Control Commission's oversight mechanisms. The corruption investigations span multiple jurisdictions and involve various schemes, from direct cash payments to shell company arrangements designed to circumvent ownership disclosure requirements. Federal prosecutors have charged more than a dozen individuals, including public officials, cannabis entrepreneurs, and consultants who allegedly exploited the state's social equity provisions. The trials and ongoing investigations have exposed how political influence and financial incentives corrupted a licensing process intended to remedy past drug war harms. For investors, operators, and policymakers nationwide, the Massachusetts cases serve as a cautionary tale about the governance challenges inherent in emerging cannabis markets.

Why This Matters

The Massachusetts corruption cases threaten to undermine public confidence in regulated cannabis markets and jeopardize the legitimacy of social equity programs designed to address decades of discriminatory enforcement. The stakes extend far beyond individual criminal prosecutions. Massachusetts operates one of the largest adult-use cannabis markets on the East Coast, with more than 400 licensed retailers generating over $1.8 billion in annual sales as of 2026. The corruption scandals have cast doubt on the integrity of the licensing process that determined which applicants received valuable permits in this lucrative market. License values in Massachusetts metropolitan areas can exceed $5 million, creating powerful incentives for corruption. Social equity applicants—individuals from communities disproportionately harmed by cannabis prohibition—were supposed to receive priority consideration and technical assistance. The corruption cases revealed that some politically connected individuals exploited these programs, obtaining equity certifications through fraudulent means or using equity applicants as fronts for hidden ownership interests. This abuse has damaged the credibility of equity programs nationwide, providing ammunition to critics who question whether such initiatives can be implemented without corruption. For patients and consumers, the scandals raise concerns about product safety and regulatory compliance. When licenses are awarded based on bribes rather than merit, the result may be operators who prioritize profit over quality control and regulatory adherence. The Cannabis Control Commission has faced criticism for inadequate oversight that allowed corrupt actors to operate for years before federal prosecutors intervened. The cases also have significant implications for interstate cannabis policy. Massachusetts was among the first East Coast states to implement adult-use legalization, and other states have modeled aspects of their programs on the Massachusetts framework. The corruption revelations have prompted policymakers in New York, Connecticut, and other states to scrutinize their own licensing processes and implement additional safeguards.

Background and History

The roots of Massachusetts cannabis corruption trace back to the state's 2016 ballot initiative legalizing adult-use marijuana and the subsequent scramble for limited licenses in a market projected to generate billions in revenue.

Legalization and Initial Framework (2016-2018)

Massachusetts voters approved Question 4 in November 2016 by a margin of 53.7% to 46.3%, legalizing possession and cultivation of cannabis for adults 21 and older. The ballot measure established the Cannabis Control Commission as the regulatory authority and mandated that the agency prioritize applicants from communities disproportionately impacted by marijuana prohibition. The law took effect December 15, 2016, but commercial sales would not begin until November 2018. The legislature substantially rewrote the voter-approved law in July 2017 through Chapter 55 of the Acts of 2017, increasing the tax rate from 12% to 20%, delaying the retail launch by six months, and expanding municipal control over local licensing. These changes created additional points of leverage for political influence, as applicants now needed approval from both state regulators and local officials. The dual-approval requirement would later feature prominently in corruption schemes. Governor Charlie Baker appointed the five-member Cannabis Control Commission in September 2017. The commission faced the enormous task of developing comprehensive regulations, processing thousands of applications, and launching a new industry from scratch. The rushed timeline and political pressure to begin sales created conditions where thorough vetting of applicants became difficult.

The Priority Certification Controversy (2018-2020)

The commission implemented a Social Equity Program and Economic Empowerment Priority Certification in March 2019, offering expedited review, reduced fees, and technical assistance to qualifying applicants. To qualify, individuals needed to demonstrate either residence in an area of disproportionate impact or evidence of a past drug conviction, along with majority ownership of the applicant entity. Almost immediately, industry observers raised concerns about fraudulent certifications. Some applicants appeared to use nominal equity participants as fronts while actual control remained with well-funded, predominantly white investors. The commission's verification process relied heavily on applicant attestations without rigorous independent investigation of ownership structures or financial arrangements. By 2020, federal investigators had begun examining whether some applicants obtained priority certifications through misrepresentation and whether public officials received payments to facilitate approvals. The U.S. Attorney's Office for the District of Massachusetts opened multiple grand jury investigations, issuing subpoenas to the Cannabis Control Commission, municipal governments, and individual license holders.

The Fall River Cases (2020-2022)

The first major corruption case to become public involved Jasiel Correia, the former mayor of Fall River, Massachusetts. Federal prosecutors charged Correia in October 2018 with wire fraud and tax offenses related to a smartphone app business, but the investigation expanded to include cannabis-related bribery allegations. In September 2020, a superseding indictment charged Correia with extorting marijuana vendors and demanding hundreds of thousands of dollars in bribes from individuals seeking to open cannabis businesses in Fall River. According to prosecutors, Correia used his authority over local licensing to extract payments, often funneled through intermediaries to disguise the transactions. Correia was convicted in May 2021 on multiple counts and sentenced to six years in federal prison. The Fall River prosecutions revealed a pattern that would recur in subsequent cases: public officials leveraging their control over local approvals to demand payments from desperate applicants facing tight regulatory deadlines. The cases also exposed the role of intermediaries—consultants and attorneys who facilitated corrupt payments while maintaining plausible deniability.

The Tompkins Indictment (2024-Present)

The most significant case emerged in March 2024 when federal prosecutors indicted Suffolk County Sheriff Steven Tompkins on extortion and bribery charges. The indictment alleged that Tompkins, who oversaw the Suffolk County Sheriff's Department since 2013, demanded payments from multiple cannabis license applicants between 2019 and 2023 in exchange for using his political influence to facilitate approvals. According to the indictment, Tompkins solicited payments ranging from $25,000 to $100,000 from applicants seeking licenses in Boston and surrounding communities. Prosecutors alleged that Tompkins threatened to use his political connections to block applications if payments were not made, and promised to advocate with state regulators and local officials on behalf of those who paid. The scheme allegedly generated more than $400,000 in illicit payments. The Tompkins case is particularly significant because of his prominent position in Massachusetts law enforcement and Democratic Party politics. Tompkins served as president of the Massachusetts Sheriffs' Association and maintained close relationships with state legislators and Boston city officials. His alleged corruption demonstrated how political influence could be monetized in the cannabis licensing process. Tompkins pleaded not guilty and his trial is scheduled to begin in August 2026. His attorneys have indicated they will argue that any payments received were legitimate consulting fees for services unrelated to his official position.

Related Prosecutions and Investigations (2023-2026)

The Tompkins case is part of a broader web of prosecutions. In June 2023, federal prosecutors charged David Torrisi, a political consultant, with acting as a conduit for bribe payments to public officials from cannabis applicants. Torrisi pleaded guilty in January 2024 and is cooperating with ongoing investigations. In November 2024, the Cannabis Control Commission revoked the licenses of three Boston-area dispensaries after determining that the applicants had obtained priority certifications through fraudulent representations about ownership and control. The commission found that the nominal equity owners had no meaningful decision-making authority and that actual control rested with undisclosed investors who had made payments to political intermediaries. State-level investigations have also intensified. The Massachusetts State Ethics Commission opened multiple inquiries into whether public officials violated conflict-of-interest laws by participating in cannabis licensing decisions while having undisclosed financial relationships with applicants. The Massachusetts Office of Campaign and Political Finance has examined whether cannabis industry contributions to political campaigns were linked to favorable regulatory treatment.

Key Players

Steven Tompkins

Steven Tompkins served as Suffolk County Sheriff from 2013 until his indictment in 2024. A lifelong Boston resident, Tompkins built a political career on criminal justice reform advocacy, implementing programs to reduce recidivism and improve conditions at the Suffolk County House of Correction. His public stance supporting cannabis legalization and social equity made the corruption allegations particularly damaging. Tompkins maintained his innocence and initially refused to resign, but was suspended without pay following his indictment. His trial, beginning in August 2026, is expected to feature testimony from multiple cannabis applicants who allegedly made payments.

Cannabis Control Commission

The Cannabis Control Commission serves as Massachusetts' primary regulatory authority for medical and adult-use cannabis. The five-member commission, appointed by the governor, treasurer, and attorney general, has faced sustained criticism for inadequate oversight that allowed corrupt actors to obtain and maintain licenses. Chair Shannon O'Brien, who joined the commission in 2021, has implemented enhanced verification procedures for social equity certifications and increased coordination with law enforcement. However, critics argue the commission remains understaffed and lacks the investigative resources to detect sophisticated fraud schemes.

U.S. Attorney's Office, District of Massachusetts

Federal prosecutors have led the corruption investigations, using wire fraud, extortion, and Hobbs Act statutes to charge public officials and intermediaries. Acting U.S. Attorney Joshua Levy has made cannabis corruption a priority, assigning a dedicated team of prosecutors and FBI agents to the cases. The federal approach has been more aggressive than state enforcement, with prosecutors using cooperating witnesses and financial records to build conspiracy cases. The decision to pursue federal charges rather than relying on state authorities reflects skepticism about local political will to prosecute well-connected defendants.

David Torrisi

David Torrisi, a Boston-area political consultant, emerged as a central figure in multiple corruption schemes. According to court documents, Torrisi acted as a middleman, collecting payments from cannabis applicants and delivering them to public officials in exchange for favorable treatment. Torrisi's cooperation agreement with prosecutors, signed in January 2024, requires him to provide testimony and documents about his interactions with numerous officials and applicants. His testimony is expected to be crucial in the Tompkins trial and other pending cases.

Social Equity Applicants and Advocates

Legitimate social equity applicants have been collateral damage in the corruption scandals. Organizations like the Massachusetts Recreational Consumer Council and the Minority Cannabis Business Association have advocated for reforms to protect genuine equity participants while preventing fraud. These groups have called for increased transparency in ownership verification, dedicated funding for equity technical assistance, and expedited license processing that reduces opportunities for extortion. Some equity applicants have reported being approached by consultants offering to facilitate approvals through political connections, forcing them to choose between paying questionable fees or facing indefinite delays.

Legal and Regulatory Framework

The Massachusetts corruption prosecutions rely on federal criminal statutes that prohibit extortion, bribery, and honest services fraud, even though cannabis remains illegal under federal law. The primary federal statute used in these cases is the Hobbs Act, 18 U.S.C. § 1951, which prohibits extortion affecting interstate commerce. Prosecutors have successfully argued that cannabis businesses, despite violating the Controlled Substances Act, engage in interstate commerce through their purchase of equipment, payment processing, and other activities. This allows federal prosecution of extortion targeting cannabis applicants, even though the underlying business involves federally illegal conduct. Wire fraud charges under 18 U.S.C. § 1343 have been used to prosecute false statements in license applications and fraudulent representations about social equity qualifications. The honest services fraud theory, 18 U.S.C. § 1346, applies when public officials deprive citizens of their right to honest government services through bribery or kickback schemes. At the state level, Massachusetts General Laws Chapter 268A governs conflicts of interest for public employees. The statute prohibits officials from participating in matters in which they have a financial interest and from using their positions to secure unwarranted privileges. The State Ethics Commission has authority to investigate violations and impose civil penalties, though criminal prosecution requires referral to district attorneys. The Cannabis Control Commission operates under Chapter 94G of the Massachusetts General Laws and 935 CMR 500.000 of the Code of Massachusetts Regulations. These provisions establish licensing requirements, including background checks, financial disclosures, and verification of social equity qualifications. The regulations require applicants to disclose all individuals with direct or indirect control and any person who will receive more than 10% of gross revenues. However, enforcement has been inconsistent, and the commission lacks subpoena power to compel production of documents from non-licensees. The regulatory framework creates multiple veto points where corruption can occur. Applicants must obtain both state Cannabis Control Commission approval and local authorization from municipal governments. Many municipalities require host community agreements negotiating community impact fees and local benefits. This dual-approval system, combined with limited licenses in desirable locations, creates scarcity that drives up the value of political influence.

Impact on the Massachusetts Cannabis Market

The corruption scandals have created uncertainty for investors, delayed license approvals, and increased compliance costs across the Massachusetts cannabis industry. License values in prime Massachusetts markets have fluctuated significantly as corruption cases unfolded. In Boston and Cambridge, retail license values peaked at approximately $6 million in early 2023 before declining to $4-4.5 million by mid-2026 as regulatory uncertainty increased. Investors have become more cautious about acquiring licenses with unclear ownership histories, fearing potential revocation if undisclosed corruption is later discovered. Multi-state operators active in Massachusetts, including Curaleaf, Trulieve, and Verano, have faced enhanced scrutiny of their license acquisition histories. The Cannabis Control Commission has required these companies to provide detailed documentation of all payments to consultants, attorneys, and political figures during the application process. This has delayed expansion plans and increased legal costs. The social equity program has been particularly damaged. Legitimate equity applicants report difficulty securing investment because potential backers fear association with a tainted program. Some equity license holders have sold their businesses at discounts to avoid ongoing regulatory scrutiny. The number of new social equity applications declined by 40% between 2024 and 2026, according to commission data. Wholesale cannabis prices in Massachusetts have remained relatively stable despite the scandals, with average wholesale flower prices ranging from $1,800 to $2,400 per pound in mid-2026. However, some cultivators report that retailers are demanding price concessions to offset increased compliance costs and legal fees related to ownership verification requirements. The corruption cases have also affected banking access. Financial institutions already wary of serving cannabis businesses have imposed additional due diligence requirements on Massachusetts operators, demanding detailed documentation of ownership structures and political contributions. This has increased operational costs and forced some smaller operators to rely more heavily on cash transactions.

What Experts Say

Cannabis policy researchers have pointed to the Massachusetts cases as evidence that social equity programs require more robust oversight mechanisms. According to analysis by the RAND Corporation's Drug Policy Research Center, equity programs that rely on applicant self-certification without independent verification are vulnerable to fraud. The researchers recommend third-party audits of ownership structures and ongoing monitoring of equity participants' actual involvement in business operations. Legal experts specializing in cannabis regulation have noted that the dual-approval system in Massachusetts creates more opportunities for corruption than single-regulator models. Attorneys who represent cannabis clients have observed that the host community agreement process, which requires applicants to negotiate directly with municipal officials, is particularly susceptible to extortion because negotiations occur in private with limited oversight. Law enforcement officials have emphasized that cannabis corruption cases are resource-intensive because they require tracing complex financial relationships and proving quid pro quo arrangements. Federal prosecutors have noted that many corrupt payments are structured to appear as legitimate consulting fees or campaign contributions, requiring extensive financial analysis to establish criminal intent. Social equity advocates have expressed frustration that fraudulent actors have undermined programs designed to remedy past injustices. Community organizations in Boston's Dorchester and Roxbury neighborhoods have documented how the corruption scandals have made it harder for legitimate equity applicants to secure investment and community support. Industry consultants have reported that compliance costs in Massachusetts have increased substantially as operators seek to ensure their ownership structures and political relationships can withstand regulatory scrutiny. Some consulting firms have stopped offering government relations services to cannabis clients to avoid potential legal exposure.

What's Next

The Tompkins trial beginning in August 2026 will be the most significant test of federal prosecutors' corruption cases and could lead to additional indictments of public officials and cannabis industry figures. The trial is expected to last three to four weeks and feature testimony from multiple cannabis applicants who allegedly made payments to Tompkins through intermediaries. Prosecutors have indicated they will present financial records showing payments to shell companies controlled by Tompkins associates, followed by expenditures benefiting Tompkins personally. The defense is expected to argue that Tompkins provided legitimate consulting services and that any advocacy he performed was not connected to his official duties as sheriff. A conviction would likely prompt additional cooperation from defendants in related cases and could lead to new indictments. Federal prosecutors have indicated that their investigation remains active and that additional charges are possible. Defense attorneys representing other targets of the investigation are watching the trial closely to assess the strength of the government's evidence and the viability of various defense strategies. The Cannabis Control Commission has proposed regulatory reforms scheduled for public hearing in September 2026. The proposed changes would require third-party verification of social equity qualifications, mandatory disclosure of all consulting and lobbying expenditures exceeding $5,000, and enhanced background checks for individuals with indirect ownership interests. The commission is also considering a prohibition on license transfers within the first three years of operation to prevent quick-flip schemes. The Massachusetts legislature is considering several bills to address corruption vulnerabilities. House Bill 2847 would require public disclosure of all host community agreement terms and prohibit municipal officials from participating in negotiations if they have received campaign contributions from the applicant within the previous two years. Senate Bill 1653 would increase the Cannabis Control Commission's investigative budget and grant the agency subpoena power to compel document production during license reviews. Additional trials are scheduled for late 2026 and early 2027 involving other public officials and cannabis industry figures. The outcomes of these cases will determine whether the corruption was limited to a few bad actors or represented systemic problems requiring more fundamental reform. Civil litigation is also expected to increase. License holders whose applications were denied or delayed may file lawsuits seeking damages if they can prove that competitors obtained approvals through corrupt payments. Some municipalities are considering litigation to recover community impact fees paid under host community agreements tainted by corruption.

State-by-State Context

While Massachusetts has experienced the most extensive cannabis corruption prosecutions, similar issues have emerged in other states with competitive licensing regimes.

Illinois

Illinois has faced corruption allegations involving its social equity lottery system for cannabis licenses. In 2022, federal prosecutors charged a state legislator with accepting payments from applicants seeking favorable treatment in the lottery process. The case revealed that some applicants with political connections received advance notice of application requirements and assistance with submissions. Illinois subsequently reformed its lottery system and implemented enhanced conflict-of-interest rules for officials involved in cannabis licensing.

New York

New York's Office of Cannabis Management has struggled with similar challenges as it implements the state's social equity-focused licensing program. In 2025, state investigators found that some applicants for conditional cultivation licenses had misrepresented their ownership structures to qualify as equity participants. The state revoked several licenses and implemented more stringent verification procedures. New York officials have studied the Massachusetts cases to identify vulnerabilities in their own system.

California

California has experienced corruption at the local level, where municipalities control licensing decisions. In 2021, federal prosecutors charged the mayor of Adelanto with accepting bribes from cannabis companies seeking local approvals. Similar cases have occurred in other California cities, leading to calls for state-level licensing to reduce local corruption opportunities. However, California's strong home-rule tradition has prevented centralization of licensing authority.

Ohio

Ohio's medical cannabis licensing process has been marred by allegations of favoritism and conflicts of interest, though criminal prosecutions have been limited. Losing applicants filed lawsuits alleging that the scoring process was rigged to favor politically connected applicants. The state settled several cases and implemented reforms to increase transparency in future licensing rounds.

Implications for Investors and Operators

The Massachusetts corruption cases have fundamentally changed due diligence practices for cannabis industry investors and increased the compliance burden for operators nationwide. Private equity firms and institutional investors now conduct extensive background investigations of license acquisition histories before investing in cannabis companies. This includes reviewing all payments to consultants, attorneys, and political figures during the application process, examining host community agreements for unusual terms, and verifying the legitimacy of social equity certifications. Some investors have walked away from otherwise attractive deals after discovering questionable political relationships or unexplained consulting payments. Multi-state operators have implemented enhanced compliance protocols to prevent corruption issues in their operations. These include prohibitions on payments to government officials or their family members, mandatory disclosure of all lobbying and government relations activities, and regular audits of ownership structures to ensure compliance with disclosure requirements. Some companies have hired former prosecutors and regulators to oversee compliance programs. Insurance companies have begun offering cannabis-specific directors and officers liability policies that cover legal defense costs related to corruption investigations. However, these policies typically exclude coverage for criminal fines and penalties, and premiums have increased substantially as the risk profile has become clearer. Lenders providing debt financing to cannabis companies have added representations and warranties to loan agreements requiring borrowers to certify that licenses were obtained without corrupt payments and that ownership structures comply with all disclosure requirements. Breach of these provisions can trigger default and acceleration of the loan. The corruption scandals have also affected valuations in merger and acquisition transactions. Buyers are demanding indemnification for losses resulting from license revocations or regulatory sanctions related to pre-closing conduct, and are conducting more extensive due diligence on the target company's political relationships and licensing history.

Further Reading

• United States v. Steven Tompkins, Criminal Docket No. 24-CR-10087 (D. Mass.), indictment and case documents available through PACER (Public Access to Court Electronic Records)
• Massachusetts Cannabis Control Commission, Social Equity Program regulations and guidance, 935 CMR 500.105, available at https://mass-cannabis-control.com/
• Massachusetts General Laws Chapter 94G, Regulation of the Use and Distribution of Marijuana Not Medically Prescribed, full statutory text
• U.S. Attorney's Office, District of Massachusetts, press releases on cannabis corruption cases, available at https://www.justice.gov/usao-ma
• Massachusetts State Ethics Commission, Advisory opinions and enforcement actions related to cannabis industry conflicts of interest, available at https://www.mass.gov/ethics-commission
• RAND Corporation Drug Policy Research Center, "Lessons from Cannabis Social Equity Programs: Preventing Fraud While Promoting Access" (2025)
• 18 U.S.C. § 1951 (Hobbs Act), full text of federal extortion statute
• 18 U.S.C. § 1343 (Wire Fraud), full text of federal wire fraud statute
• Massachusetts General Laws Chapter 268A, Conduct of Public Officials and Employees, conflict of interest statute
• Cannabis Control Commission meeting minutes and licensing data, archived at https://mass-cannabis-control.com/about/meetings/